Related Experiment Video
Updated: Nov 27, 2025

08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.2K
Early Versus Delayed Pacemaker for Heart Block After Valve Surgery: A Cost-Effectiveness Analysis.
Jared P Beller1, Zachary Tyerman1, J Hunter Mehaffey1
1Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.
The Journal of Surgical Research
|December 6, 2020
Summary
Watchful waiting for pacemaker insertion is a cost-effective strategy for acute atrioventricular block after valve surgery. This approach offers higher utility and is preferred over early pacemaker implantation, despite initial higher costs.
Area of Science:
- Cardiology
- Health Economics
- Medical Device Management
Background:
- High-grade atrioventricular block post-valve surgery often resolves, but predicting recovery is challenging.
- Management strategies for pacemaker implantation timing require cost-effectiveness evaluation.
Purpose of the Study:
- To compare the cost-effectiveness of early pacemaker implantation versus watchful waiting for acute atrioventricular block after valve surgery.
Main Methods:
- A cost-effectiveness model analyzed short- and long-term outcomes, including complications, recovery rates, and quality-adjusted life years (QALYs) over 20 years.
- Decision analysis compared early pacemaker placement (5 days) against watchful waiting (12 days) based on a 36.7% recovery rate at 12 days.
Main Results:
- Watchful waiting resulted in higher utility (9.05 QALYs) but was more costly ($171,798) than early implantation (8.55 QALYs; $165,436).
- The incremental cost-effectiveness ratio for watchful waiting was $12,724 per QALY.
- Results were sensitive to variations in quality-adjusted survival and atrioventricular node recovery rates.
Conclusions:
- Watchful waiting is a cost-effective strategy for managing acute atrioventricular block post-valve surgery compared to early pacemaker insertion.
- While cost-effective for the population, clinical risk scores are needed for personalized patient decision-making regarding pacemaker timing.

